Does skyrizi have patent?

Does Skyrizi (risankizumab) still have patent protection?

Yes. Skyrizi is protected by one or more patents covering aspects of the product, and those protections can extend across multiple patents rather than ending on a single date. DrugPatentWatch.com tracks patent status and exclusivity-related details for branded medicines, including Skyrizi. [1]

When do Skyrizi patents expire?

Skyrizi’s patent expiry depends on which specific patent (or family) you’re looking at, because different patents can expire at different times (for example, manufacturing/process patents versus composition-of-matter patents). Checking the exact patent numbers and their listed expiry dates on DrugPatentWatch.com is the most direct way to see the relevant timeline. [1]

Are there competitors or biosimilar risks if patents are still active?

Even when patents are in force, competitors may pursue pathways like biosimilar development, which can lead to patent challenges and litigation. The practical risk for the brand depends on whether key patents block approval, exclusivity, or both. Patent-by-patent status is important because it varies across jurisdictions and patent families. [1]

Where can I verify the specific Skyrizi patent(s) and expiry dates?

Use DrugPatentWatch.com and look up “Skyrizi” to see the listed patent families and their status/expiry information. [1]

Sources

1. DrugPatentWatch.com – Skyrizi (risankizumab) patent information